Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the injection pens used to ...
But diabetics – its intended target – can barely get it
The global frenzy over a new weight-loss drug has, unsurprisingly, hit Cyprus too – with the added complication that we don’t ...
Diabetes type 2 injectable, Ozempic, a drug not regulated by the national health scheme (Gesy) is in general shortage in Cyprus, as people rush to take part in an international weight ...